Quantcast

Latest MedImmune Stories

2015-04-22 08:35:33

GAITHERSBURG, Md., April 22, 2015 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC) today announced that the Board of Directors of GenVec, Inc.

2015-04-16 04:21:54

OXFORD, England, April 16, 2015 /PRNewswire/ -- Immunocore Limited, a world-leading biotechnology company developing novel biological drugs to treat cancer and other diseases,

2015-03-27 08:26:17

SHANGHAI, March 27, 2015 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc.

2015-03-16 08:30:12

-- Steady Progress in All Programs; Two Phase 2 Clinical Trials to Start in 2015 -- ROCKVILLE, Md., March 16, 2015 /PRNewswire/ --

2015-03-02 12:31:46

GAITHERSBURG, Md., March 2, 2015 /PRNewswire/ -- VLP Therapeutics, LLC.

2015-01-29 23:05:57

University of Maryland researchers are covering soap bubbles with biomaterials that act as a disguise, tricking the body’s cells into mistaking the capsule for a bacterium, a cancer cell or

2015-01-09 12:24:29

NORWALK, Conn., Jan.

2014-11-24 08:27:47

Clinical Development, Manufacturing Expertise, and Scale Critical to Success WHITEHOUSE STATION, N.J. and AMES, IA, Nov.


Word of the Day
deuteragonist
  • A person in a secondary role, specifically the second most important character (after the protagonist).
The word 'deuteragonist' comes from a Greek word meaning 'an actor of second-class parts'.
Related